Jang, J. H., Lekue, C. B., Burgues, J. M. B., Calado, R., Chang, Y., Czyz, J., Frairia, C., Hernandez, I., Kim, H., Kim, J. S., Koh, Y., Marceau, D., Mauad, V. A. Q., Mun, Y., Park, S., Ramalho, F., Sahin, F., Notaro, R., Sica, S., Yenerel, M., Mitchell, A., Dong, X., Perlee, L. (2025). Study design of A phase 3, open-label trial for pozelimab and cemdisiran combination therapy in patients with paroxysmal nocturnal hemoglobinuria with inadequate control of intravascular hemolysis. Blood. https://doi.org/10.1182/blood-2025-4988